Month: <span>March 2019</span>

Home / 2019 / March
Post

Testosterone slows prostate cancer recurrence in low-risk patients

In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients. This may call into question the general applicability of Nobel-Prize winning hormonal prostate treatment. The work is presented at the European Association of Urology congress in Barcelona. Doctors have long regarded testosterone as a hormone which promotes prostate cancer. The 1941 work of Huggins and Hodges won Huggins...

Post

Novel electrocardiogram uses signals from ear and hand to check heart rhythm

A novel electrocardiogram (ECG) method which uses signals from the ear and hand to check heart rhythm is revealed today at EHRA 2011 a European Society of Cardiology (ESC) congress. The ECG does not require two hands and could be used by drivers, athletes, and the military. Study author Dr. Raffaele De Lucia, of the University Hospital of Pisa, Italy, said: “Mobile ECG devices present a major opportunity to...

Post

Newer heart valves may let more people avoid surgery

By MARILYNN MARCHIONE Surgery for certain bad heart valves may soon become a thing of the past. New studies suggest it’s OK and often better to have a new valve placed through a tube into an artery instead. The results are expected to quickly transform treatment of a problem that affects millions of people — a stiff or narrowed aortic valve that...

Post

Tilt training prevents fainting

Worry and fear about fainting reduced and patients returned to work EUROPEAN SOCIETY OF CARDIOLOGY Lisbon, Portugal – 18 March 2019: Tilt training effectively prevents fainting, according to research presented today at EHRA 2019, a European Society of Cardiology (ESC) congress.1 The programme also improved quality of life, reduced the worry and fear about future fainting and enabled patients to return to work. “Our...

Post

Prescription fish oil pill lowers heart attack risk in those already on statins

by Alan Mozes, Healthday Reporter  (HealthDay) —Patients who have high triglycerides and take cholesterol-lowering statins to lower their risk for heartattack or stroke can cut that risk by another 30 percent by adding a high-dose omega-3 fatty acid pill, investigators report. The prescription drug, called Vascepa, is not to be confused with over-the-counter dietary omega-3 (often fish oil) supplements. Such supplements typically contain far lower doses of the critical omega-3...

Post

Study recommends new ways to treat musculoskeletal pain

by  University of Western Australia A new study led by The University of Western Australia has identified 11 recommendations to help health professionals and patients better manage musculoskeletal problems. The study comes after the team found many musculoskeletalproblems were not being managed effectively. Musculoskeletal conditions – including back and neck pain, osteoarthritis and shoulder pain – affect nearly 7 million Australians with around one in five visits to the doctor due...

Post

TGen and ABL pursue global rollout of advanced TB test

In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories (ABL), to market and distribute TGen’s patented Next Generation Sequencing based TB test technology. For now, the test—called DeepChek-TB—is available for research...

Post

Case study: Bartonella and sudden-onset adolescent schizophrenia

NORTH CAROLINA STATE UNIVERSITY In a new case study, researchers at North Carolina State University describe an adolescent human patient diagnosed with rapid onset schizophrenia who was found instead to have a Bartonella henselae infection. This study adds to the growing body of evidence that Bartonellainfection can mimic a host of chronic illnesses, including mental illness, and could open up new avenues of research into bacterial or...

Post

Active interventions generally helpful for urinary incontinence

(HealthDay)—Most active interventions are more likely than no treatment to improve outcomes for women with either stress or urgency urinary incontinence (UI), according to a review published online March 19 in the Annals of Internal Medicine. Ethan M. Balk, M.D., from Brown University in Providence, Rhode Island, and colleagues compared the effectiveness of pharmacologic and nonpharmacologic interventions to improve or cure stress, urgency, or mixed...